| Aspect | Key points | Evidence (citation IDs) | Year/Source (short) |
|---|---|---|---|
| Molecular function | Prkaa2 encodes AMPKα2, the catalytic α2 subunit of the heterotrimeric AMPK Ser/Thr kinase. AMPKα2 phosphorylates metabolic targets including ACC/ACAC (canonical readout; ACC Ser79 commonly used), HMGCR, and autophagy regulators such as ULK1; recent reviews also note mitochondrial fission target MFF Ser172. Overall role is to suppress anabolic metabolism and promote catabolic, ATP-restoring pathways. | (pqac-00000000, pqac-00000008, pqac-00000009) | 2025 Feng review; 2025 Rakoubian review; 2025 Mohanty review |
| Activation and regulation | Core activation is phosphorylation of AMPKα2 at Thr172 by upstream kinases, especially LKB1; CaMKKβ/CAMKK2 provides a Ca2+-responsive route. AMP/ADP binding to γ promotes allostery, favors Thr172 phosphorylation, and protects from dephosphorylation. AXIN-LKB1 lysosomal signaling helps couple glucose starvation to AMPK-dependent mTORC1 inhibition; ADaM-site ligands stabilize AMPK and protect Thr172. | (pqac-00000003, pqac-00000007, pqac-00000008, pqac-00000014, pqac-00000018) | 2025 Rakoubian review; 2024 Ashraf review; 2023 Li primary; 2024 figure summary |
| Localization | AMPKα2 shows isoform-biased nuclear localization/shuttling, whereas α1 is mainly cytosolic. Reviews summarize that α2 contains a nuclear localization signal and can shuttle to the nucleus; α1 carries a nuclear export sequence. In heart, α2 is described as present in both cytosol and nucleus and enriched in cardiomyocytes. | (pqac-00000000, pqac-00000002, pqac-00000007, pqac-00000019) | 2025 Feng review; 2025 Rakoubian review; 2024 Ashraf review/figure context |
| Isoform-specific role: ketone metabolism | A 2024 primary study identified a specific AMPKα2 role in skeletal-muscle ketone utilization: fasting AMPKα2ΔMusc mice showed ~2-fold higher blood BHB, and AMPKα2ΔMyo mice ~1.5–1.6-fold higher blood BHB after 48 h fasting versus WT; AMPKα2 loss slowed BHB clearance. Mechanistically, AMPKα2 binds and stabilizes SCOT, limiting SCOT ubiquitination/degradation. | (pqac-00000012, pqac-00000013, pqac-00000016, pqac-00000017) | 2024 Zhang et al., Scientific Reports |
| Isoform specificity and tissue distribution | α2 is preferentially enriched in skeletal muscle, cardiac muscle, and liver and can be more AMP responsive than α1. In heart, α2 is the predominant catalytic isoform and α1 does not fully compensate for α2 loss in stress adaptation. | (pqac-00000001, pqac-00000002, pqac-00000007) | 2025 Kim review; 2025 Rakoubian review; 2024 Ashraf review |
| Pathways/processes | Major downstream processes include inhibition of mTORC1, activation of autophagy/mitophagy, stimulation of mitochondrial adaptation/biogenesis, and broad metabolic reprogramming during nutrient stress and exercise. | (pqac-00000008, pqac-00000011, pqac-00000015) | 2025 Rakoubian review; 2025 Malik review; 2023 Jang primary |
| Example context: NAFLD | In NAFLD models, Thrap3 suppresses AMPK-mediated autophagy; liver Thrap3 knockout enhanced cytosolic translocation of AMPK from the nucleus, increased AMPK activation, improved mitochondrial function, and reduced lipid accumulation, supporting therapeutic interest in restoring AMPK signaling. | (pqac-00000015) | 2023 Jang et al., Exp Mol Med |
| Example context: cardiotoxicity | In a 2024 cardiotoxicity study, impaired PRKAA/AMPK signaling contributed to defective autophagosome-lysosome fusion during crizotinib injury; metformin restored AMPK-related signaling and rescued cardiomyocyte/cardiac injury phenotypes. ACC Ser79 phosphorylation was used as a PRKAA target readout. | (pqac-00000008) | 2024 Xu et al., Autophagy |
| Example context: endothelial shear stress / vascular biology | Recent vascular review literature describes AMPK, including PRKAA2/AMPKα2, as a mechanosensitive endothelial regulator linking laminar shear stress to metabolic adaptation and vascular protection; it is discussed as a therapeutic target in cardiovascular disease. | (pqac-00000005) | 2024 Hauger & Hordijk review |


*Table: This table summarizes the core functional annotation of rat Prkaa2/AMPKα2, including molecular activity, activation mechanisms, localization, isoform-specific phenotypes, and representative disease contexts. It is useful as a compact evidence map tying recent literature to functional interpretation.*